SCIENCE IN (Germany) Performance
| 8D9 Stock | EUR 0.31 0.01 3.13% |
The firm has a beta of -0.62, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning SCIENCE IN are expected to decrease at a much lower rate. During the bear market, SCIENCE IN is likely to outperform the market. At this point, SCIENCE IN SPORT has a negative expected return of -0.11%. Please make sure to validate SCIENCE IN's downside deviation, information ratio, and the relationship between the semi deviation and coefficient of variation , to decide if SCIENCE IN SPORT performance from the past will be repeated in the future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days SCIENCE IN SPORT has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
SCIENCE |
SCIENCE IN Relative Risk vs. Return Landscape
If you would invest 34.00 in SCIENCE IN SPORT on December 22, 2024 and sell it today you would lose (3.00) from holding SCIENCE IN SPORT or give up 8.82% of portfolio value over 90 days. SCIENCE IN SPORT is currently producing negative expected returns and takes up 2.9776% volatility of returns over 90 trading days. Put another way, 26% of traded stocks are less volatile than SCIENCE, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
SCIENCE IN Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SCIENCE IN's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SCIENCE IN SPORT, and traders can use it to determine the average amount a SCIENCE IN's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0364
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 8D9 |
Estimated Market Risk
| 2.98 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average SCIENCE IN is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SCIENCE IN by adding SCIENCE IN to a well-diversified portfolio.
SCIENCE IN Fundamentals Growth
SCIENCE Stock prices reflect investors' perceptions of the future prospects and financial health of SCIENCE IN, and SCIENCE IN fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SCIENCE Stock performance.
| Return On Equity | -0.29 | |||
| Return On Asset | -0.0764 | |||
| Profit Margin | (0.19) % | |||
| Operating Margin | (0.13) % | |||
| Shares Outstanding | 172.42 M | |||
| Revenue | 65.55 M | |||
| EBITDA | (5.75 M) | |||
| Cash And Equivalents | 10.47 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 860 K | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 0.28 X | |||
| Cash Flow From Operations | 3.14 M | |||
| Earnings Per Share | (0.06) X | |||
About SCIENCE IN Performance
By analyzing SCIENCE IN's fundamental ratios, stakeholders can gain valuable insights into SCIENCE IN's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SCIENCE IN has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SCIENCE IN has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, and sports and fitness enthusiasts. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom. SCIENCE IN is traded on Frankfurt Stock Exchange in Germany.Things to note about SCIENCE IN SPORT performance evaluation
Checking the ongoing alerts about SCIENCE IN for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SCIENCE IN SPORT help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SCIENCE IN SPORT generated a negative expected return over the last 90 days | |
| SCIENCE IN SPORT has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 65.55 M. Net Loss for the year was (1.73 M) with profit before overhead, payroll, taxes, and interest of 31.35 M. | |
| Over 94.0% of the company shares are owned by institutions such as pension funds |
- Analyzing SCIENCE IN's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SCIENCE IN's stock is overvalued or undervalued compared to its peers.
- Examining SCIENCE IN's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SCIENCE IN's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SCIENCE IN's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SCIENCE IN's stock. These opinions can provide insight into SCIENCE IN's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for SCIENCE Stock analysis
When running SCIENCE IN's price analysis, check to measure SCIENCE IN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCIENCE IN is operating at the current time. Most of SCIENCE IN's value examination focuses on studying past and present price action to predict the probability of SCIENCE IN's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCIENCE IN's price. Additionally, you may evaluate how the addition of SCIENCE IN to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |